Results 281 to 290 of about 1,839,177 (303)

RNA-modifying proteins as anticancer drug targets

Nature Reviews Drug Discovery, 2018
Robert A Copeland
exaly  

Aminoglycoside modifying enzymes

Drug Resistance Updates, 2010
Marcelo E Tolmasky, Maria Soledad Ramirez   +1 more
exaly  

Modified Cryoprobe

Archives of Ophthalmology, 1981
openaire   +2 more sources

Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trial

Lancet, The, 2018
Désirée M Van Der Heijde, James C-C Wei, Maxime Dougados   +2 more
exaly  

MODIFIED LARYNGOSCOPE

The Lancet, 1951
openaire   +2 more sources

Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial

Lancet, The, 2012
Alasdair J Coles, Douglas L Arnold, Jeffrey A Cohen   +2 more
exaly  

Modified Gingivectomy

The Journal of Periodontology, 1951
openaire   +2 more sources

Gaia Modified

Science, 1988
openaire   +2 more sources

Modified Shoe

Physical Therapy, 1964
openaire   +2 more sources

Chromatin-modifying enzymes as modulators of reprogramming

Nature, 2012
Nergis Kara, Amit U Sinha, Patrick Cahan
exaly